Piramal Pharma Ltd. To Invest Minority Stake In Yapan Bio, India-Based Cdmo Providing Expertise In Biologics And Vaccines
Piramal Pharma Ltd. To Invest Minority Stake In Yapan Bio, India-Based Cdmo Providing Expertise In Biologics And Vaccines
12/21/21, 1:45 AM
Location
mumbaiPiramal Pharma Limited (PPL) today announced an investment of INR101.77cr in Yapan Bio Pvt Ltd ("Yapan") of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment. As PPS continues to strengthen its capabilities and position itself as a leading CDMO, this acquisition marks a significant addition to PPS' global capabilities in the development and manufacturing of large molecules for human clinical trials.
Company Info
Location
mumbai, maharashtra, india
Additional Info
Yapan Bio Pvt Ltd, located in Genome Valley in Hyderabad, has been founded by Atin Tomar and Nirav Desai, both having ~40 years of combined experience in the biotechnology industry, globally, specializing in the fields of development, manufacturing and commercialization of Vaccines and Biologics/Bio-therapeutics. Yapan Bio is a Contract Process Development and Manufacturing Organization (CDMO) providing process development, scale-up and complaint GMP manufacturing of Vaccines and Biologics/Bio-therapeutics for human clinical trials across the world. Capabilities at Yapan includes development and GMP facilities for high containment product classes (up to BSL-2+).
For more information visit https://www.yapanbio.com
SOURCE Piramal Pharma Solutions